<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04595396</url>
  </required_header>
  <id_info>
    <org_study_id>CONBIOETICA09-CEI-001-20160404</org_study_id>
    <nct_id>NCT04595396</nct_id>
  </id_info>
  <brief_title>Laparoscopic Gastric Bypass as Metabolic Surgery in Obesity Class 1</brief_title>
  <official_title>Gastric Bypass as Metabolic Surgery in Obesity Class 1: a Prospective Study of the Short, Mid and Long Term Results Among Mexicans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CARLOS ZERRWECK LOPEZ</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Tlahuac</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective study including Mexican patients diagnosed with type 2 diabetes and class 1&#xD;
      obesity, undergoing laparoscopic gastric bypass. The objective was to determine short,&#xD;
      mid-and long-term outcomes (weight loss, metabolic, morbidity and diabetes remission). A&#xD;
      subanalysis was included, based on preoperative usage of one (Group A) or more antidiabetics&#xD;
      ± insulin (Group B).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2012</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: weight (kilograms)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>24 months</time_frame>
    <description>Measure: weight (kilograms)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>36 months</time_frame>
    <description>Measure: weight (kilograms)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: Body Mass Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>24 months</time_frame>
    <description>Measure: Body Mass Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>36 months</time_frame>
    <description>Measure: Body Mass Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: % excess weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>24 months</time_frame>
    <description>Measure: % excess weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>36 months</time_frame>
    <description>Measure: % excess weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>12 months</time_frame>
    <description>Measure: % total weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>24 months</time_frame>
    <description>Measure: % total weight loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>36 months</time_frame>
    <description>Measure: % total weight loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete Diabetes Remission</measure>
    <time_frame>12 months</time_frame>
    <description>Definition: no antidiabetic drugs while on glucose &lt;100 mg/dl and HbA1C% &lt;6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete Diabetes Remission</measure>
    <time_frame>24 months</time_frame>
    <description>Definition: no antidiabetic drugs while on glucose &lt;100 mg/dl and HbA1C% &lt;6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete Diabetes Remission</measure>
    <time_frame>36 months</time_frame>
    <description>Definition: no antidiabetic drugs while on glucose &lt;100 mg/dl and HbA1C% &lt;6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late complications</measure>
    <time_frame>After 30 days from surgery</time_frame>
    <description>Complications requiring re-admssion / re-operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early complications</measure>
    <time_frame>First 30 days after surgery</time_frame>
    <description>Complications requiring re-admssion / re-operation</description>
  </secondary_outcome>
  <enrollment type="Actual">51</enrollment>
  <condition>Type2 Diabetes</condition>
  <condition>Bariatric Surgery Candidate</condition>
  <condition>Laparoscopic Gastric Bypass</condition>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Gastric Bypass</intervention_name>
    <description>The LGBP was performed using a classic Roux-en-Y procedure. Briefly, a gastric pouch of 30-50 cc was constructed with an antecolic calibrated gastro-jejunal anastomosis (mechanical anastomosis using a 2.5 mm load). The biliary and alimentary limbs measured ≈70 cm and ≈150 cm, respectively, and the jejuno-jejunal anastomosis was also performed in a latero-lateral fashion (mechanical anastomosis using a 2.5 mm load). Mesenteric defects were closed with running non-absorbable sutures and the omentum was divided in every case</description>
    <other_name>Roux-en-y gastric bypass</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Mexican patients with T2DM submitted to laparoscopic gastric bypass&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria Any sex &gt;18 years-old &lt;60 years-old Class 1 obesity (BMI 30-34.9 kg/m2)&#xD;
        Type-2 diabetes mellitus diagnosis (with or without medication) Submitted to laparoscopic&#xD;
        gastric bypass&#xD;
&#xD;
        Exclusion criteria Other bariatric surgery Revisional surgery Incomplete charts&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital General Tlahuac</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Tlahuac</investigator_affiliation>
    <investigator_full_name>CARLOS ZERRWECK LOPEZ</investigator_full_name>
    <investigator_title>Professor and Head of Department.</investigator_title>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>obesity class 1</keyword>
  <keyword>metabolic surgery</keyword>
  <keyword>laparoscopic gastric bypass</keyword>
  <keyword>type-2 diabetes mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

